======= ANGPT4 =======
== Gene Information ==
* **Official Symbol**: ANGPT4
* **Official Name**: angiopoietin 4
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=51378|51378]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9Y264|Q9Y264]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=ANGPT4&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ANGPT4|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/603705|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Binds to TEK/TIE2, modulating ANGPT1 signaling. Can induce tyrosine phosphorylation of TEK/TIE2. Promotes endothelial cell survival, migration and angiogenesis. {ECO:0000269|PubMed:15284220}.
|Fibrinogen C|
|transmembrane receptor protein tyrosine kinase activator activity|
|activation of transmembrane receptor protein tyrosine kinase activity|
|endothelial cell proliferation|
|negative regulation of blood vessel endothelial cell migration|
|negative regulation of endothelial cell migration|
|positive regulation of blood vessel endothelial cell migration|
|receptor tyrosine kinase binding|
|negative regulation of epithelial cell migration|
|epithelial cell proliferation|
|regulation of blood vessel endothelial cell migration|
|positive regulation of endothelial cell migration|
|negative regulation of angiogenesis|
|negative regulation of blood vessel morphogenesis|
|negative regulation of vasculature development|
|Notch signaling pathway|
|positive regulation of epithelial cell migration|
|regulation of endothelial cell migration|
|positive regulation of angiogenesis|
|positive regulation of vasculature development|
|cellular response to hypoxia|
|positive regulation of peptidyl-tyrosine phosphorylation|
|cellular response to decreased oxygen levels|
|cellular response to oxygen levels|
|regulation of epithelial cell migration|
|regulation of peptidyl-tyrosine phosphorylation|
|negative regulation of cell migration|
|negative regulation of cell motility|
|regulation of angiogenesis|
|negative regulation of cellular component movement|
|angiogenesis|
|regulation of vasculature development|
|negative regulation of locomotion|
|activation of protein kinase activity|
|response to hypoxia|
|response to decreased oxygen levels|
|leukocyte migration|
|response to oxygen levels|
|blood vessel morphogenesis|
|blood vessel development|
|positive regulation of cell migration|
|transmembrane receptor protein tyrosine kinase signaling pathway|
|vasculature development|
|cardiovascular system development|
|positive regulation of cell motility|
|positive regulation of protein kinase activity|
|positive regulation of cellular component movement|
|positive regulation of locomotion|
|cell population proliferation|
|positive regulation of kinase activity|
|tube morphogenesis|
|positive regulation of transferase activity|
|enzyme linked receptor protein signaling pathway|
|regulation of protein kinase activity|
|cellular protein-containing complex assembly|
|tube development|
|regulation of cell migration|
|circulatory system development|
|regulation of kinase activity|
|negative regulation of apoptotic process|
|anatomical structure formation involved in morphogenesis|
|negative regulation of programmed cell death|
|regulation of cell motility|
|negative regulation of developmental process|
|cell migration|
|regulation of transferase activity|
|regulation of locomotion|
|regulation of cellular component movement|
|negative regulation of cell death|
|positive regulation of protein phosphorylation|
|positive regulation of phosphorylation|
|regulation of anatomical structure morphogenesis|
|cell motility|
|localization of cell|
|positive regulation of phosphorus metabolic process|
|positive regulation of phosphate metabolic process|
|response to abiotic stimulus|
|negative regulation of multicellular organismal process|
|positive regulation of protein modification process|
|locomotion|
|positive regulation of developmental process|
|positive regulation of catalytic activity|
|regulation of protein phosphorylation|
|regulation of apoptotic process|
|movement of cell or subcellular component|
|protein-containing complex assembly|
|regulation of programmed cell death|
|regulation of phosphorylation|
|extracellular space|
|positive regulation of cellular protein metabolic process|
|regulation of cell death|
|cellular response to stress|
|positive regulation of protein metabolic process|
|positive regulation of multicellular organismal process|
|positive regulation of molecular function|
|regulation of phosphate metabolic process|
|regulation of phosphorus metabolic process|
|regulation of protein modification process|
|protein-containing complex subunit organization|
|extracellular region|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp71|KU-0063794 3.8μM R02 exp71]]|-1.7|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 13396
* **Expression level (log2 read counts)**: 1.53
{{:chemogenomics:nalm6 dist.png?nolink |}}